Graham K Crompton

Summary

Publications

  1. ncbi How to achieve good compliance with inhaled asthma therapy
    Graham K Crompton
    Respiratory Unit, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, Scotland
    Respir Med 98:S35-40. 2004
  2. ncbi Intravenous magnesium sulphate provides no additive benefit to standard management in acute asthma
    Tracey A Bradshaw
    Respiratory Unit, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK
    Respir Med 102:143-9. 2008
  3. ncbi Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD
    Federico Lavorini
    Unità Funzionale di Medicina Respiratoria, Universita degli Studi di Firenze, Italy
    Respir Med 102:593-604. 2008
  4. ncbi Moving from CFC aerosol to HFA aerosol or dry powder inhalers: what do patients think?
    Thomas K Hartung
    Respiratory Department, Ninewells Hospital, Dundee, UK
    Respiration 69:314-9. 2002
  5. ncbi Aerosol delivery devices
    Graham K Crompton
    Chest 129:1388-9; author reply 1389. 2006
  6. ncbi Issues in inhalation therapy: a new series of papers from the ADMIT Working Group
    P N Richard Dekhuijzen
    Prim Care Respir J 16:335-6. 2007

Detail Information

Publications6

  1. ncbi How to achieve good compliance with inhaled asthma therapy
    Graham K Crompton
    Respiratory Unit, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, Scotland
    Respir Med 98:S35-40. 2004
    ..The Novolizer has all the desirable features listed above and is expected to improve compliance if prescribed for the large number of patients who cannot use the conventional pMDI or less efficient DPSs...
  2. ncbi Intravenous magnesium sulphate provides no additive benefit to standard management in acute asthma
    Tracey A Bradshaw
    Respiratory Unit, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK
    Respir Med 102:143-9. 2008
    ..Magnesium sulphate (MgSO(4)) is known to have a bronchodilator effect on smooth muscle but studies have shown conflicting results on its efficacy in acute asthma, although its use is recommended in national and international guidelines...
  3. ncbi Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD
    Federico Lavorini
    Unità Funzionale di Medicina Respiratoria, Universita degli Studi di Firenze, Italy
    Respir Med 102:593-604. 2008
    ..Incorrect usage of inhaler devices might have a major influence on the clinical effectiveness of the delivered drug. This issue is poorly addressed in management guidelines...
  4. ncbi Moving from CFC aerosol to HFA aerosol or dry powder inhalers: what do patients think?
    Thomas K Hartung
    Respiratory Department, Ninewells Hospital, Dundee, UK
    Respiration 69:314-9. 2002
    ..It is uncertain whether these new formulations with different properties are acceptable to patients. Similarly, switching a patient to a dry powder inhaler (DPI) carries the risk of non-acceptance...
  5. ncbi Aerosol delivery devices
    Graham K Crompton
    Chest 129:1388-9; author reply 1389. 2006
  6. ncbi Issues in inhalation therapy: a new series of papers from the ADMIT Working Group
    P N Richard Dekhuijzen
    Prim Care Respir J 16:335-6. 2007